Anesthesiology and Surgical Critical Care Department, Hospital La Paz, Madrid, Spain.
J Clin Microbiol. 2013 Feb;51(2):518-21. doi: 10.1128/JCM.02469-12. Epub 2012 Nov 28.
Data on biliary carriage of bacteria and, specifically, of bacteria with worrisome and unexpected resistance traits (URB) are lacking. A prospective study (April 2010 to December 2011) was performed that included all patients admitted for <48 h for elective laparoscopic cholecystectomy in a Spanish hospital. Bile samples were cultured and epidemiological/clinical data recorded. Logistic regression models (stepwise) were performed using bactobilia or bactobilia by URB as dependent variables. Models (P < 0.001) showing the highest R(2) values were considered. A total of 198 patients (40.4% males; age, 55.3 ± 17.3 years) were included. Bactobilia was found in 44 of them (22.2%). The presence of bactobilia was associated (R(2) Cox, 0.30) with previous biliary endoscopic retrograde cholangiopancreatography (ERCP) (odds ratio [OR], 8.95; 95% confidence interval [CI], 2.96 to 27.06; P < 0.001), previous admission (OR, 2.82; 95% CI, 1.10 to 7.24; P = 0.031), and age (OR, 1.09 per year; 95% CI, 1.05 to 1.12; P < 0.001). Ten out of the 44 (22.7%) patients with bactobilia carried URB: 1 Escherichia coli isolate (CTX-M), 1 Klebsiella pneumoniae isolate (OXA-48), 3 high-level gentamicin-resistant enterococci, 1 vancomycin-resistant Enterococcus isolate, 3 Enterobacter cloacae strains, and 1 imipenem-resistant Pseudomonas aeruginosa strain. Bactobilia by URB (versus those by non-URB) was only associated (R(2) Cox, 0.19) with previous ERCP (OR, 11.11; 95% CI, 1.98 to 62.47; P = 0.006). For analyses of patients with bactobilia by URB versus the remaining patients, previous ERCP (OR, 35.284; 95% CI, 5.320 to 234.016; P < 0.001), previous intake of antibiotics (OR, 7.200; 95% CI, 0.962 to 53.906; P = 0.050), and age (OR, 1.113 per year of age; 95% CI, 1.028 to 1.206; P = 0.009) were associated with bactobilia by URB (R(2) Cox, 0.19; P < 0.001). Previous antibiotic exposure (in addition to age and previous ERCP) was a risk driver for bactobilia by URB. This may have implications in prophylactic/therapeutic measures.
目前缺乏有关胆汁细菌携带情况的数据,特别是具有令人担忧和意外耐药特征(URB)的细菌的数据。本研究为前瞻性研究(2010 年 4 月至 2011 年 12 月),纳入了所有因择期腹腔镜胆囊切除术在西班牙医院住院<48 小时的患者。采集胆汁样本进行培养,并记录流行病学/临床数据。使用胆汁细菌或 URB 胆汁细菌作为因变量进行逐步逻辑回归模型。考虑了显示最高 R²值的模型(P<0.001)。共纳入 198 例患者(40.4%为男性;年龄 55.3±17.3 岁)。其中 44 例(22.2%)存在胆汁细菌。胆汁细菌的存在与既往胆道内镜逆行胰胆管造影术(ERCP)(R²Cox,0.30)(优势比 [OR],8.95;95%置信区间 [CI],2.96 至 27.06;P<0.001)、既往入院(OR,2.82;95%CI,1.10 至 7.24;P=0.031)和年龄(OR,每年 1.09;95%CI,1.05 至 1.12;P<0.001)相关。44 例存在胆汁细菌的患者中有 10 例(22.7%)携带 URB:1 株大肠埃希菌(CTX-M)、1 株肺炎克雷伯菌(OXA-48)、3 株高水平庆大霉素耐药肠球菌、1 株耐万古霉素肠球菌、3 株阴沟肠杆菌和 1 株耐亚胺培南铜绿假单胞菌。与非 URB 相比,仅 URB 胆汁细菌(R²Cox,0.19)与既往 ERCP 相关(OR,11.11;95%CI,1.98 至 62.47;P=0.006)。对于分析 URB 胆汁细菌的患者与其余患者,既往 ERCP(OR,35.284;95%CI,5.320 至 234.016;P<0.001)、既往使用抗生素(OR,7.200;95%CI,0.962 至 53.906;P=0.050)和年龄(OR,每年 1.113 岁;95%CI,1.028 至 1.206;P=0.009)与 URB 胆汁细菌相关(R²Cox,0.19;P<0.001)。既往抗生素暴露(除年龄和既往 ERCP 外)是 URB 胆汁细菌的一个危险因素。这可能对预防/治疗措施有影响。